THE SOURCE: Winter 2025

In this issue: Global regulatory harmonization in the spotlight in Shanghai; Industry implementation proven to protect donors; Associations between frequent plasmapheresis, biomarkers, and health outcomes: A 2-year national prospective Cohort of Repeat Donor Experiences (CORE) study; Journeys of career growth in the plasma industry; European Medicines Agency's recommendations to boost supply or anti-D immunoglobulin; High-level discussion in Brussels highlights need for tailored approaches to Critical Medicines, and more.